Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Morphine Doses in Total Hip Replacement
NCT06878014Phase 4Recruiting
- Sponsor
- Medical University of Silesia
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of morphine in postoperative pain (3 arms), sponsored by Medical University of Silesia. Primary endpoints: Analgesic efficacy at 48 hours and Safety profile at 48 hours. Started Mar 2025; status: recruiting.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06878014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06878014.